Children's Hospital Medical Center
Next-Generation Human Liver Organoid Microarray Platform Predicts Drug-Induced Liver Injury
Researchers at Cincinnati Children's Hospital Medical Center, in collaboration with Roche, have developed a next-generation human liver organoid microarray platform that can predict which drugs may cause harmful immune reactions in certain individuals. This innovative platform uses induced pluripotent stem cell-derived liver organoids combined with each donor'